< Back to situations

[ORGANIZATION]

American Society of Clinical Oncology

Featured in 7 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

291 clusters · 1104 sources · last updated

Latest: Novo Nordisk faces lawsuits over Ozempic and NAION risks

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

[QUIET] [HEALTH] [US] [AR] [GR]

FDA approves Rasonque for pancreatic cancer; access disputes

40 clusters · 304 sources · last updated

Latest: Angelica Pasculli seeks access to US cancer drug unavailable in Europe

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

[QUIET] [HEALTH] [JP]

Advancements in breast cancer treatment and diagnostics

2 clusters · 4 sources · last updated

Latest: Breast cancer treatment advances and importance of early detection in Japan

Medical advancements in breast cancer management are increasingly focusing on personalized diagnostics and targeted therapies. Research from the OPTIMA study suggests that the Prosigna genetic test, which utilizes the PA

Also covered in